Variant report
Variant | esv15630 |
---|---|
Chromosome Location | chr6:160649987-160654846 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13216396 | chr6:160650000-160650001 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs13219634 | chr6:160650003-160650004 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77008204 | chr6:160650006-160650007 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186065022 | chr6:160650024-160650025 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs80016742 | chr6:160650028-160650029 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77472942 | chr6:160650030-160650031 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386707797 | chr6:160650031-160650032 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76554700 | chr6:160650050-160650051 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190969143 | chr6:160650054-160650055 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76388548 | chr6:160650061-160650062 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78909785 | chr6:160650063-160650064 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76205243 | chr6:160650083-160650084 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76983189 | chr6:160650091-160650092 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs202120071 | chr6:160650092-160650093 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74966519 | chr6:160650093-160650094 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114241570 | chr6:160650099-160650100 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182081838 | chr6:160650155-160650156 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2774232 | chr6:160650176-160650177 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs186080005 | chr6:160650187-160650188 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76239824 | chr6:160650194-160650195 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577730525 | chr6:160650208-160650209 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191334409 | chr6:160650255-160650256 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563628732 | chr6:160650281-160650282 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138968449 | chr6:160650291-160650292 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549201036 | chr6:160650297-160650298 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77219161 | chr6:160650333-160650334 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559119504 | chr6:160650355-160650356 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533859882 | chr6:160650455-160650456 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528229397 | chr6:160650466-160650467 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112079851 | chr6:160650483-160650484 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571378362 | chr6:160650525-160650526 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142210951 | chr6:160650528-160650529 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34360089 | chr6:160650541-160650542 | Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs567987202 | chr6:160650542-160650543 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536540057 | chr6:160650543-160650544 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113968396 | chr6:160650572-160650573 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573488427 | chr6:160650579-160650580 | Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202201386 | chr6:160650636-160650637 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556028077 | chr6:160650637-160650638 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183214215 | chr6:160650735-160650736 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539203137 | chr6:160650834-160650835 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557912079 | chr6:160650913-160650914 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550723807 | chr6:160650950-160650951 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577472004 | chr6:160650958-160650959 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188617053 | chr6:160650995-160650996 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112697037 | chr6:160651027-160651028 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573927332 | chr6:160651062-160651063 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139773203 | chr6:160651066-160651067 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572462923 | chr6:160651071-160651072 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528291761 | chr6:160651096-160651097 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160640400-160651200 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr6:160644000-160668600 | Weak transcription | Aorta | Aorta |
3 | chr6:160647400-160652400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:160648800-160650000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr6:160648800-160650400 | Weak transcription | Osteobl | bone |
6 | chr6:160649200-160652000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr6:160650000-160653000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
8 | chr6:160650400-160650600 | Enhancers | Osteobl | bone |
9 | chr6:160651200-160651400 | Enhancers | Stomach Smooth Muscle | stomach |
10 | chr6:160651200-160652000 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr6:160651400-160651800 | Weak transcription | Stomach Smooth Muscle | stomach |
12 | chr6:160651800-160652200 | Enhancers | Stomach Smooth Muscle | stomach |
13 | chr6:160652000-160652200 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
14 | chr6:160652200-160655200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
15 | chr6:160652600-160653000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr6:160653000-160654800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
17 | chr6:160654800-160655400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
18 | chr6:160654800-160658800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |